The P2X7 Receptor-Interleukin-1 Liaison
Open accessAbstract
Interleukin-1β (IL-1β) plays a central role in stimulation of innate immune system and inflammation and in several chronic inflammatory diseases. These include rare hereditary conditions, e.g., auto-inflammatory syndromes, as well as common pathologies, such as type II diabetes, gout and atherosclerosis. A better understanding of IL-1β synthesis and release is particularly relevant for the design of novel anti-inflammatory drugs. One of the molecules mainly involved in IL-1β maturation is the P2X7 receptor (P2X7R), an ATP-gated ion channel that chiefly acts through the recruitment of the NLRP3 inflammasome-caspase-1 complex. In this review, we will summarize evidence supporting the key role of the P2X7R in IL-1β production, with special emphasis on the mechanism of release, a process that is still a matter of controversy. Four different models have been proposed: (i) exocytosis via secretory lysosomes, (ii) microvesicles shedding from plasma membrane, (iii) release of exosomes, and (iv) passive efflux across a leaky plasma membrane during pyroptotic cell death. All these models involve the P2X7R.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The opening of P2X7 receptor channels leads to IL-1β production mainly through NLRP3 inflammasome activation, thus contributing to the disruption of the BBB.
“The opening of P2X7 receptor channels leads to IL-1β production mainly through NLRP3 inflammasome activation [123], thus contributing to the disruption of the BBB.”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659 · see citing works
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · see citing works
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · see citing works
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · see citing works
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · see citing works
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500 · see citing works
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 3,380 · see citing works
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · see citing works
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,185 · see citing works
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080 · see citing works
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · see citing works
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · see citing works
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N., Bull, H., Calaycay, J., Chapman, K., Howard, A., Kostura, M., Miller, D. K., Molineaux, S., Weidner, J., Auniņš, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,725 · see citing works
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517 · see citing works
Inflammatory caspases are innate immune receptors for intracellular LPS
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., & Shao, F. (2014) · Nature · doi:10.1038/nature13683 · Cited by 2,285 · see citing works
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · see citing works
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · see citing works
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167 · see citing works
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · cited 3× · see citing works
“Cytokines of the IL-1 family ligate and activate specific plasma membrane receptors, the IL-1 receptor family, comprised of 10 members, named IL-1R1, IL-1R2, IL-1R3 (IL-1RAcP), IL-R4 (ST2), IL-1R5 (IL-18Rα), IL-1R6 (IL-R36), IL-1R7 (IL-18Rβ), IL-1R8 (SIGIRR: single Ig IL-1R-related molecule or TIR8: three Ig domain-co…”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. L., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,822 · see citing works
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739 · see citing works
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601 · see citing works
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
He, Y., Zeng, M. Y., Yang, D., Motro, B., & Núñez, G. (2016) · Nature · doi:10.1038/nature16959 · Cited by 1,295 · see citing works
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
Rathinam, V. A. K., & Fitzgerald, K. A. (2016) · Cell · doi:10.1016/j.cell.2016.03.046 · Cited by 1,109 · see citing works
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030 · see citing works
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025 · see citing works
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924 · see citing works
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 909 · see citing works
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897 · see citing works
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
Mackenzie, A. B., Wilson, H. L., Kiss‐Toth, E., Dower, S., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 862 · see citing works
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847 · see citing works
Consensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832 · see citing works
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y. E., Collier, K. J., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816 · see citing works
Immune cell regulation by autocrine purinergic signalling
JUNGER, W. G. (2011) · Nature reviews. Immunology · doi:10.1038/nri2938 · Cited by 813 · see citing works
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787 · see citing works
A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence.
Rubartelli, A., Cozzolino, F., Talio, M., & Sitia, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08268.x · Cited by 780 · see citing works
Perregaux, D. G., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 760 · see citing works
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 739 · see citing works
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
Gery, I., & Waksman, B. H. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.1.143 · Cited by 733 · see citing works
Purinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 716 · see citing works
Blott, E. J., & Griffiths, G. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm732 · Cited by 686 · see citing works
DAMPs from Cell Death to New Life
Vénéreau, E., Ceriotti, C., & Bianchi, M. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00422 · Cited by 666 · see citing works
Ferrari, D., Chiozzi, P., Falzoni, S., Susino, M. D., Melchiorri, L., Baricordi, O. R., & Virgilio, F. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1451 · Cited by 616 · see citing works
Self-citationPurinergic Signaling during Inflammation
Eltzschig, H. K., Mv, S., & Robson, S. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1300259 · Cited by 608 · see citing works
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 604 · see citing works
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia
Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Möller, T., Matteoli, M., & Verderio, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7268 · Cited by 596 · see citing works
Heid, M. E., Keyel, P. A., Kamga, C., Shiva, S., Watkins, S. C., & Salter, R. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301490 · Cited by 570 · see citing works
Qu, Y., Franchi, L., Nunez, G., & Dubyak, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1913 · Cited by 563 · see citing works
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 554 · see citing works
Acid sphingomyelinase activity triggers microparticle release from glial cells
Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E. H., Furlan, R., Clementi, E., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.45 · Cited by 550 · see citing works
P2X 7 Receptors Mediate ATP Release and Amplification of Astrocytic Intercellular Ca 2+ Signaling
Suadicani, S. O., Brosnan, C. F., & Scemes, E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3902-05.2006 · Cited by 512 · see citing works
Blocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494 · see citing works
Andrei, C., Dazzi, C., Lotti, L. V., Torrisi, M. R., Chimini, G., & Rubartelli, A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.5.1463 · Cited by 475 · see citing works
The Inflammasome: First Line of the Immune Response to Cell Stress
Ogura, Y., Sutterwala, F. S., & Flavell, R. A. (2006) · Cell · doi:10.1016/j.cell.2006.08.002 · Cited by 474 · see citing works
NOD-Like Receptors in Infection, Immunity, and Diseases
Kim, Y. K., Shin, J., & Nahm, M. H. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.1.5 · Cited by 460 · see citing works
Interleukin 1 is processed and released during apoptosis.
Hogquist, K. A., Nett, M. A., Unanue, E. R., & Chaplin, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8485 · Cited by 456 · see citing works
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
Karmakar, M., Katsnelson, M. A., Dubyak, G. R., & Pearlman, E. (2016) · Nature Communications · doi:10.1038/ncomms10555 · Cited by 450 · see citing works
Sneddon, P., & Westfall, D. P. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015083 · Cited by 422 · see citing works
P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrı́n, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 413 · see citing works
Osteoporosis, inflammation and ageing
Ginaldi, L., Di Benedetto, M. C., & De Martinis, M. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-14 · Cited by 412 · cited 1× · see citing works
“…mechanisms responsible for the activation of innate immunity in inherited auto-inflammatory diseases may also play a key role in sustaining inflammation in several frequent multifactorial pathologies, such as type II diabetes, gout, pseudogout, and atherosclerosis (Ginaldi et al., 2005).”
BackgroundAndrei, C., Margiocco, P., Poggi, A. D., Lotti, L. V., Torrisi, M. R., & Rubartelli, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308558101 · Cited by 409 · see citing works
The gap junction cellular internet: connexin hemichannels enter the signalling limelight
Evans, W. H., Vuyst, E. D., & Leybaert, L. (2006) · Biochemical Journal · doi:10.1042/bj20060175 · Cited by 409 · see citing works
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 395 · see citing works
The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death
Virgilio, F. D. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80045-x · Cited by 374 · see citing works
Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
Murgia, M., Hanau, S., Pizzo, P., Rippa, M., & Virgilio, F. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53082-9 · Cited by 367 · see citing works
How the immune system works to protect the host from infection: A personal view
Janeway, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131202998 · Cited by 356 · see citing works
Viganò, E., Diamond, C. E., Spreafico, R., Balachander, A., Sobota, R. M., & Mortellaro, A. (2015) · Nature Communications · doi:10.1038/ncomms9761 · Cited by 354 · see citing works
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP
Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi‐Castagnoli, P., & Virgilio, F. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1531 · Cited by 352 · see citing works
Self-citationHuman astrocytes express a novel NLRP2 inflammasome
Minkiewicz, J., Vaccari, J. P. D. R., & Keane, R. W. (2013) · Glia · doi:10.1002/glia.22499 · Cited by 328 · see citing works
Antonucci, F., Turola, E., Riganti, L., Caleo, M., Gabrielli, M., Perrotta, C., Novellino, L., Clementi, E., Giussani, P., Viani, P., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.489 · Cited by 328 · see citing works
Structural basis for subtype-specific inhibition of the P2X7 receptor
Karasawa, A., & Kawate, T. (2016) · eLife · doi:10.7554/elife.22153 · Cited by 308 · see citing works
Mechanisms of interleukin-1β release
Eder, C. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.007 · Cited by 307 · see citing works
Pelegrı́n, P., & Surprenant, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610351200 · Cited by 301 · see citing works
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation
Verderio, C., Muzio, L., Turola, E., Bergami, A., Novellino, L., Ruffini, F., Riganti, L., Corradini, I., Francolini, M., Garzetti, L., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23627 · Cited by 299 · see citing works
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T. N., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296 · see citing works
A Novel Recombinant Plasma Membrane-targeted Luciferase Reveals a New Pathway for ATP Secretion
Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., & Virgilio, F. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-03-0222 · Cited by 296 · see citing works
Self-citationThe IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294 · see citing works
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293 · see citing works
Self-citationStimulation of P2 receptors causes release of IL-1β–loaded microvesicles from human dendritic cells
Pizzirani, C., Ferrari, D., Chiozzi, P., Adinolfi, E., Sandonà, D., Savaglio, E., & Virgilio, F. D. (2006) · Blood · doi:10.1182/blood-2005-06-031377 · Cited by 280 · see citing works
Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
Martín‐Sánchez, F., Diamond, C. E., Zeitler, M., Gomez, A. I., Baroja‐Mazo, A., Bagnall, J., Spiller, D. G., White, M. H., Daniels, M. J. D., Mortellaro, A., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.176 · Cited by 279 · see citing works
K+ Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling
Katsnelson, M. J., Rucker, L. G., Russo, H. M., & Dubyak, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402658 · Cited by 278 · see citing works
Virgilio, F. D., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J. M., Venketaraman, V., & Baricordi, O. R. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400341 · Cited by 278 · see citing works
Self-citationPotassium‐inhibited processing of IL‐1 beta in human monocytes.
Walev, I., Reske, K., Palmer, M., Valeva, A., & Bhakdi, S. C. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07149.x · Cited by 278 · see citing works
Medicinal chemistry of adenosine, P2Y and P2X receptors
Jacobson, K. A., & Müller, C. E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.001 · Cited by 262 · see citing works
ATP release through pannexon channels
Dahl, G. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0191 · Cited by 261 · see citing works
X-ray structures define human P2X3 receptor gating cycle and antagonist action
Mansoor, S., Lü, W., Oosterheert, W., Shekhar, M., Tajkhorshid, E., & Gouaux, E. (2016) · Nature · doi:10.1038/nature19367 · Cited by 259 · see citing works
Response to local inflammation of IL-1 beta-converting enzyme- deficient mice
Fantuzzi, G., Ku, G., Harding, M. W., Livingston, D. J., Sipe, J. D., Kuida, K., Flavell, R. A., & Dinarello, C. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1818 · Cited by 232 · see citing works
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein
Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J. M., Sarti, A. C., Bonora, M., Pinton, P., & Di Virgilio, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268714 · Cited by 225 · see citing works
Self-citationNorth, R. A. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0427 · Cited by 191 · see citing works
P2X7 receptor regulation of non-classical secretion from immune effector cells
Dubyak, G. (2012) · Cellular Microbiology · doi:10.1111/cmi.12001 · Cited by 189 · see citing works
The participation of plasma membrane hemichannels to purinergic signaling
Baroja‐Mazo, A., Barberà-Cremades, M., & Pelegrı́n, P. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.002 · Cited by 173 · see citing works
Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation
Próchnicki, T., Mangan, M., & Latz, E. (2016) · F1000Research · doi:10.12688/f1000research.8614.1 · Cited by 173 · see citing works
The intersection of cell death and inflammasome activation
Vince, J. E., & Silke, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2205-2 · Cited by 171 · see citing works
Microglial microvesicle secretion and intercellular signaling
Turola, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00149 · Cited by 168 · see citing works
Brough, D., Feuvre, R. A. L., Wheeler, R. D., Solovyova, N. A., Hilfiker, S., Rothwell, N. J., & Verkhratsky, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3029 · Cited by 168 · see citing works
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Virgilio, F. D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 158 · see citing works
Qu, Y., Ramachandra, L., Mohr, S., Franchi, L., Harding, C. V., Núñez, G., & Dubyak, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802968 · Cited by 157 · see citing works
Temperature-elevating effect of a substance obtained from polymorphonuclear leucocytes.
Pb, B. (1948) · PubMed · Cited by 155 · see citing works
The microbial and danger signals that activate Nod-like receptors
Benkő, S., Philpott, D. J., & Girardin, S. E. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.013 · Cited by 153 · see citing works
Carta, S., Tassi, S., Semino, C., Fossati, G., Mascagni, P., Dinarello, C. A., & Rubartelli, A. (2006) · Blood · doi:10.1182/blood-2006-03-014126 · Cited by 151 · see citing works
Autophagy-dependent ATP release from dying cells via lysosomal exocytosis
Wang, Y., Martins, I., Ma, Y., Kepp, O., Galluzzi, L., & Kroemer, G. (2013) · Autophagy · doi:10.4161/auto.25873 · Cited by 137 · see citing works
Perregaux, D. G., Barberia, J. T., Lanzetti, A. J., Geoghegan, K. F., Carty, T. J., & Gabel, C. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1294 · Cited by 135 · see citing works
Ability of Human Leukocytic Pyrogen to Stimulate Brain Prostaglandin Synthesis In Vitro
Dinarello, C. A., & Bernheim, H. A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12544.x · Cited by 135 · see citing works
Gudipaty, L., Munetz, J., Verhoef, P. A., & Dubyak, G. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00070.2003 · Cited by 126 · see citing works
Ramachandra, L., Qu, Y., Wang, Y., Lewis, C. J., Cobb, B. A., Takatsu, K., Boom, W. H., Dubyak, G., & Harding, C. V. (2010) · Infection and Immunity · doi:10.1128/iai.01089-09 · Cited by 121 · see citing works
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 111 · see citing works
Facci, L., Barbierato, M., Marinelli, C., Argentini, C., Skaper, S. D., & Giusti, P. (2014) · Scientific Reports · doi:10.1038/srep06824 · Cited by 109 · see citing works
Jiang, L., Baldwin, J. M., Roger, S., & Baldwin, S. A. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00055 · Cited by 105 · see citing works
Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP
Virgilio, F. D. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(00)00114-4 · Cited by 88 · see citing works
Go It Alone No More—P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels
Dubyak, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.042077 · Cited by 87 · see citing works
The P2X7 receptor: Shifting from a low- to a high-conductance channel — An enigmatic phenomenon?
Alves, L. A., Reis, R. A. D. M., de Souza, C. A. M., de Freitas, M. S., Teixeira, P. C. N., Ferreira, D. N. M., & Xavier, R. F. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.015 · Cited by 83 · see citing works
P2X Receptors and Inflammation
Virgilio, F. D. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141210155311 · Cited by 81 · see citing works
Release of Endogenous Pyrogen by Human Monocytes
Bodel, P. T., & Atkins, E. (1967) · New England Journal of Medicine · doi:10.1056/nejm196705042761803 · Cited by 76 · see citing works
Dendritic Cell IL-1α and IL-1β Are Polyubiquitinated and Degraded by the Proteasome
Ainscough, J. S., Gerberick, G. F., Zahedi-Nejad, M., López‐Castejón, G., Brough, D., Kimber, I., & Dearman, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595686 · Cited by 61 · see citing works
Rada, B., Park, J. J.-Y., Sil, P., Geiszt, M., & Leto, T. L. (2014) · Inflammation Research · doi:10.1007/s00011-014-0756-y · Cited by 58 · see citing works
Alarmins and Antitumor Immunity
Nie, Y., Yang, D., & Oppenheim, J. J. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.021 · Cited by 57 · see citing works
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
Salaro, E., Rambaldi, A., Falzoni, S., Amoroso, F., Franceschini, A., Sarti, A. C., Bonora, M., Cavazzini, F., Rigolin, G. M., Ciccone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep26280 · Cited by 56 · see citing works
Self-citationP2 Purinoceptors in the Immune System
Virgilio, F. D., Ferrari, D., Falzoni, S., Chiozzi, P., Munerati, M., Steinberg, T. H., & Baricordi, O. R. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514900.ch17 · Cited by 52 · see citing works
Self-citationSanman, L. E., van der Linden, W. A., Verdoes, M., & Bogyo, M. S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.05.019 · Cited by 51 · see citing works
Wewers, M. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403971101 · Cited by 49 · see citing works
Electrodiffusional ATP movement through CFTR and other ABC transporters
Cantiello, H. F. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100639 · Cited by 39 · see citing works
Studies on the Isolation of the Factor Responsible for Tissue Injury in Inflammation
Menkin, V. (1943) · Science · doi:10.1126/science.97.2511.165 · Cited by 27 · see citing works
Grimes, L., & Young, M. T. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867321999141212131457 · Cited by 20 · see citing works
Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431
Hauser, C., Dayer, J., Jaunin, F., Rochemonteix, B. G.-D., & Saurat, J. ‐. (1986) · Cellular Immunology · doi:10.1016/0008-8749(86)90009-2 · Cited by 19 · see citing works
Sources of Leukocytic Endogenous Mediator in the Rat
Kampschmidt, R. F., Pulliam, L. A., & Upchurch, H. F. (1973) · Experimental Biology and Medicine · doi:10.3181/00379727-144-37703 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Role of Inflammation in the Pathogenesis of Osteoarthritis
Chow, Y. Y., & Chin, K. (2020) · Mediators of Inflammation · doi:10.1155/2020/8293921 · Cited by 536 · see citing works
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 401 · see citing works
Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review
Cheng, R., Wu, Z., Li, M., Shao, M., & Hu, T. (2020) · International Journal of Oral Science · doi:10.1038/s41368-019-0068-8 · Cited by 304 · see citing works
Burnstock, G., & Knight, G. E. (2018) · Purinergic Signalling · doi:10.1007/s11302-017-9593-0 · Cited by 248 · see citing works
Sluyter, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2017_59 · Cited by 235 · see citing works
Extracellular nucleotides and nucleosides as signalling molecules
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.006 · Cited by 218 · see citing works
Self-citationP2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217 · see citing works
Damage-associated molecular patterns in trauma
Relja, B., & Land, W. G. (2019) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-019-01235-w · Cited by 218 · see citing works
Vujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205 · see citing works
P2X receptor channels in chronic pain pathways
Bernier, L., Ase, A. R., & Séguéla, P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13957 · Cited by 199 · see citing works
Kong, H., Zhao, H., Chen, T., Song, Y., & Cui, Y. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04786-w · Cited by 185 · see citing works
Quan, J., Huang, R., Wang, Z., Huang, S., Choi, I.-W., Zhou, Y. J., Lee, Y., & Chu, J. (2018) · Parasites & Vectors · doi:10.1186/s13071-017-2573-y · Cited by 172 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Akhtar‐Schäfer, I., Wang, L., Krohne, T. U., Xu, H., & Langmann, T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708259 · Cited by 127 · see citing works
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115 · see citing works
Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
Zheng, Q., Li, S., Li, X., & Liu, R. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00509-z · Cited by 106 · see citing works
Li, X., Zhang, M., Huang, X., Liang, W. P., Li, G., Lu, X., Li, Y., Pan, H., Shi, L., Zhu, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19935-y · Cited by 99 · see citing works
P2X7 Receptor: A Potential Therapeutic Target for Depression?
Deussing, J. M., & Arzt, E. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.005 · Cited by 97 · see citing works
Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis
Hauser, C. J., & Otterbein, L. E. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0963-2 · Cited by 91 · see citing works
P2X7 receptor antagonism: Implications in diabetic retinopathy
Platania, C. B. M., Giurdanella, G., Paola, L. D., Leggio, G. M., Drago, F., Salomone, S., & Bucolo, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.001 · Cited by 85 · see citing works
Su, W.-J., Zhang, T., Jiang, C.-L., & Wang, W. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00412 · Cited by 84 · see citing works
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 82 · see citing works
Huang, S., Dong, W., Lin, X., Xu, K., Li, K., Xiong, S., Wang, Z., Nie, X., & Bian, J.-S. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.018 · Cited by 82 · see citing works
Serum amyloid A primes microglia for ATP-dependent interleukin-1β release
Facci, L., Barbierato, M., Zusso, M., Skaper, S. D., & Giusti, P. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1205-6 · Cited by 79 · see citing works
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 78 · see citing works
Self-citationDanger signals: Chemotherapy enhancers?
Vargas, T. R., & Apétoh, L. (2017) · Immunological Reviews · doi:10.1111/imr.12581 · Cited by 73 · see citing works
The Tumor Microenvironment in Colorectal Cancer Therapy
Pedrosa, L., Esposito, F. M., Thomson, T. M., & Maurel, J. (2019) · Cancers · doi:10.3390/cancers11081172 · Cited by 69 · see citing works
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68 · see citing works
Betaine Inhibits Interleukin-1β Production and Release: Potential Mechanisms
Xia, Y., Chen, S., Zhu, G., Huang, R., Yin, Y., & Ren, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02670 · Cited by 61 · see citing works
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor
Platania, C. B. M., Lazzara, F., Fidilio, A., Fresta, C. G., Conti, F., Giurdanella, G., Leggio, G. M., Salomone, S., Drago, F., & Bucolo, C. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.010 · Cited by 61 · see citing works
Shaping of Innate Immune Response by Fatty Acid Metabolite Palmitate
Tzeng, H., Chyuan, I., & Chen, W.-Y. (2019) · Cells · doi:10.3390/cells8121633 · Cited by 50 · see citing works
P2X7, a critical regulator and potential target for bone and joint diseases
Zeng, D., Yao, P., & Zhao, H. W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27544 · Cited by 50 · see citing works
Inflammatory Response During Myocardial Infarction
Oliveira, J., Soares, A. A. S. M., & Sposito, A. C. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.12.002 · Cited by 50 · see citing works
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Marcuzzi, A., Melloni, E., Zauli, G., Romani, A., Secchiero, P., Maximova, N., & Rimondi, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011241 · Cited by 49 · see citing works
Su, Y., Lian, J., Hodgson, J., Zhang, W., & Deng, C. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab087 · Cited by 49 · see citing works
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Illés, P., Rubini, P., Huang, L., & Tang, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1575811 · Cited by 49 · see citing works
Gürsel (2018) · doi:10.1016/j.neubiorev.2018.02.005 · Cited by 47 · see citing works
Novel biologics targeting the P2X7 ion channel.
Koch-Nolte, F., Eichhoff, A., Pinto-Espinoza, C., Schwarz, N., Schäfer, T., Menzel, S., Haag, F., Demeules, M., Gondé, H., & Adriouch, S. (2019) · Current opinion in pharmacology (Print) · doi:10.1016/j.coph.2019.03.001 · Cited by 44 · see citing works
ATP-Gated P2X7 Receptors Require Chloride Channels To Promote Inflammation in Human Macrophages
Janks, L., Sprague, R. S., & Egan, T. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801101 · Cited by 45 · see citing works
Hou, L., Cui, Z., Sun, P., Piao, H.-Q., Han, X., Song, J., Wang, G., Zheng, S., Dong, X.-X., Gao, L., et al. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103700 · Cited by 43 · see citing works
The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
Giuliani, A. L., Berchan, M., Sanz, J. M., Passaro, A., Pizzicotti, S., Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00793 · Cited by 42 · see citing works
Self-citationPeripheral Inflammatory Hyperalgesia Depends on P2X7 Receptors in Satellite Glial Cells
Neves, A. F., Farias, F. H., de Magalhães, S. F., Araldi, D., Pagliusi, M., Tambeli, C. H., Sartori, C. R., Lotufo, C. M. D. C., & Parada, C. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00473 · Cited by 42 · see citing works
Fresta, C. G., Caruso, G., Fidilio, A., Platania, C. B. M., Musso, N., Caraci, F., Drago, F., & Bucolo, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239305 · Cited by 41 · see citing works
Zhang, Q., Tao, X., Xia, S., Qu, J., Song, H., Liu, J., Li, H., & Shang, D. (2018) · Oncology Reports · doi:10.3892/or.2018.6844 · Cited by 40 · see citing works
P2X7 receptor in cardiovascular disease: The heart side
Martinez, C. G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13079 · Cited by 40 · see citing works
Valade, G., Libert, N., Martinaud, C., Vicaut, É., Banzet, S., & Peltzer, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749659 · Cited by 40 · see citing works
Diezmos, E. F., Markus, I., Perera, D. S., Gan, S., Zhang, L., Sandow, S. L., Bertrand, P. P., & Liu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00865 · Cited by 39 · see citing works
Zhang, Y., Jiang, M., Cui, B., Jin, C. H., Wu, Y., Shang, Y., Yang, H., Wu, M., Liu, J., Qiao, C., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15007 · Cited by 39 · see citing works
Purinergic signaling and tumor microenvironment in cervical Cancer
Pfaffenzeller, M. S., Franciosi, M. L. M., & Cardoso, A. M. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09693-3 · Cited by 39 · see citing works
P2 Purinergic Signaling in the Distal Lung in Health and Disease
Wirsching, E., Fauler, M., Fois, G., & Frick, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144973 · Cited by 40 · see citing works
Novak, I., & Solini, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.002 · Cited by 38 · see citing works
Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
Menzel, S., Schwarz, N., Haag, F., & Koch‐Nolte, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00266 · Cited by 38 · see citing works
ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles
Soni, S., O'Dea, K. P., Tan, Y. Y., Cho, K., Abe, E., Romano, R., Jiang, C., Ma, D., Sarathchandra, P., Wilson, M. R., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802386r · Cited by 38 · see citing works
The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: A new therapeutic target?
Pacheco, P. A. F., & Faria, R. X. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12960 · Cited by 38 · see citing works
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Li, Q., Zhu, X., Song, W., Peng, X., & Zhao, R. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03379-4 · Cited by 36 · see citing works
Yang, M., Qiu, R., Wang, W., Liu, J., Jin, X., Li, Y., Li, L., & Lei, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5520644 · Cited by 35 · see citing works
Lu, Y., Chen, C., Huang, J., Tian, Y., Xie, X., Yang, P., Wu, M., Tang, C., & Zhang, W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14811 · Cited by 35 · see citing works
To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?
Stokes, L., Bidula, S. M., Bibič, L., & Allum, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00627 · Cited by 35 · see citing works
Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders
Huang, L., Otrokocsi, L., & Sperlágh, B. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.030 · Cited by 34 · see citing works
The Extracellular NADome Modulates Immune Responses
Audrito, V., Messana, V. G., Brandimarte, L., & Deaglio, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.704779 · Cited by 34 · see citing works
Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout
Zhu, W., Deng, Y., & Zhou, X. (2018) · The Open Rheumatology Journal · doi:10.2174/1874312901812010094 · Cited by 33 · see citing works
Lavagna, A., Auger, J.-P., Dumesnil, A., Roy, D., Girardin, S. E., Gisch, N., Segura, M., & Gottschalk, M. G. (2019) · Veterinary Research · doi:10.1186/s13567-019-0670-y · Cited by 32 · see citing works
Jordan, P. M., Andreas, N., Groth, M., Wegner, P., Weber, F., Jäger, U., Küchler, C., Werz, O., Serfling, E., Kamradt, T., et al. (2021) · Immunology · doi:10.1111/imm.13386 · Cited by 31 · see citing works
Modulating ion channel function with antibodies and nanobodies
Stortelers, C., Pinto-Espinoza, C., Hoorick, D. V., & Koch‐Nolte, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.02.003 · Cited by 27 · see citing works
Su, Q.-Q., Tian, Y., Liu, Z., Ci, L., & Lv, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.012 · Cited by 28 · see citing works
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction
Khalafalla, M. G., Woods, L. T., Jasmer, K. J., Forti, K. M., Camden, J. M., Jensen, J. L., Limesand, K. H., Galtung, H. K., & Weisman, G. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00222 · Cited by 28 · see citing works
Song, J., Cui, Z., Lian, L., Han, X., Hou, L., Wang, G., Gao, L., Zhu, Y., Jiang, Y., Dou, J.-Y., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01978 · Cited by 28 · see citing works
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
Engel, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065410 · Cited by 28 · see citing works
P2X7 receptor antagonists for the treatment of systemic inflammatory disorders
Gelin, C. F., Bhattacharya, A., & Letavic, M. A. (2020) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2019.11.002 · Cited by 28 · see citing works
Yin, Y., Wei, L., Caseley, E. A., Lopez‐Charcas, O., Wei, Y., Li, D., Muench, S. P., Roger, S., Wang, L., & Jiang, L. (2023) · Medicinal Research Reviews · doi:10.1002/med.21952 · Cited by 25 · see citing works
Zhang, Q., Hu, F., Guo, F., Zhou, Q., Xiang, H., & Shang, D. (2019) · Oncology Reports · doi:10.3892/or.2019.7270 · Cited by 27 · see citing works
Zhang, R., Su, K., Yang, L., Tang, M., Zhao, M., Ye, N., Cai, X., Jiang, X., Li, N., Peng, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00837 · Cited by 26 · see citing works
Role of the NLRP3 inflammasome in diabetes and its complications (Review)
Jiao, X., & Tian, G. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13657 · Cited by 28 · see citing works
MSU Crystals induce sterile IL-1β secretion via P2X7 receptor activation and HMGB1 release
Marinho, Y., Marques-da-Silva, C., Santana, P. T., Chaves, M. M., Tamura, A. S., Rangel, T. P., Silva, I. V. G. E., Guimarães, M. Z. P., & Coutinho‐Silva, R. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.129461 · Cited by 26 · see citing works
Ratajczak, M. Z., Adamiak, M., Bujko, K., Thapa, A. K., Pensato, V., Kucia, M., Ratajczak, J., & Ulrich, H. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09698-y · Cited by 26 · see citing works
ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols
Nuka, E., Ohnishi, K., Terao, J., & Kawai, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204229 · Cited by 26 · see citing works
Almeida-da-Silva, C. L. C., Ramos‐Junior, E. S., Morandini, A. C., Rocha, G. D. C., Marinho, Y., Tamura, A. S., de Andrade, K. Q., Bellio, M., Savio, L. E. B., Scharfstein, J., et al. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.10.008 · Cited by 25 · see citing works
Bhat, E. A., & Sajjad, N. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04002-3 · Cited by 25 · see citing works
Signal Pathways and Markers Involved in Acute Lung Injury Induced by Acute Pancreatitis
Zhou, J., Zhou, P., Zhang, Y., Wang, G., & Fan, Z. (2021) · Disease Markers · doi:10.1155/2021/9947047 · Cited by 26 · see citing works
Manfredini, M., Giuliani, A. L., Ruina, G., Gafà, R., Bosi, C., Zoppas, E., Virgilio, F. D., & Bettoli, V. (2019) · Dermatology · doi:10.1159/000502026 · Cited by 25 · see citing works
Self-citationCoccurello, R., & Volonté, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00199 · Cited by 25 · see citing works
P2x7 receptors control demyelination and inflammation in the cuprizone model
Bernal‐Chico, A., Manterola, A., Cipriani, R., Katona, I., Matute, C., & Mato, S. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100062 · Cited by 24 · see citing works
Efficacy of novel selective NLRP3 inhibitors in human and murine retinal pigment epithelial cells
Wang, L., Schmidt, S., Larsen, P. P., Meyer, J. H., Roush, W. R., Latz, E., Holz, F. G., & Krohne, T. U. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01753-5 · Cited by 24 · see citing works
Xu, S.-L., Yu, L., Liu, W., Zhu, X., Liu, D., Tong, M.-L., Liu, L., & Lin, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106344 · Cited by 24 · see citing works
Guan, F., Jiang, W., Bai, Y., Hou, X., Jiang, C., Zhang, C., Jacques, M. L., Liu, W., & Lei, J. (2021) · Infection and Immunity · doi:10.1128/iai.00683-20 · Cited by 23 · see citing works
Dysregulation of inflammasome activation in glioma
Sim, J., Park, J., Moon, J., & Lim, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01255-5 · Cited by 23 · see citing works
DuBreuil, D. M., Soto, E. J. L., Daste, S., Meir, R., Li, D., Wainger, B. J., Fleischmann, A., & Lipscombe, D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0195-21.2021 · Cited by 22 · see citing works
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20 · see citing works
Purinergic-associated immune responses in neurodegenerative diseases
Carracedo, S., Launay, A., Déchelle-Marquet, P.-A., Faivre, É., Blum, D. L., Delarasse, C., & Boué‐Grabot, É. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102693 · Cited by 19 · see citing works
The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics
Mugisho, O. O., & Green, C. R. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108911 · Cited by 20 · see citing works
NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases
Ramalingam, V. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115915 · Cited by 19 · see citing works
Gutiérrez-López, T. Y., Orduña-Castillo, L. B., Hernández-Vásquez, M. N., Vázquez‐Prado, J., & Reyes‐Cruz, G. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.028 · Cited by 18 · see citing works
Frank, M. G., Baratta, M. V., Zhang, K., Fallon, I. P., Pearson, M. A., Liu, G., Hutchinson, M. R., Watkins, L. R., Goldys, E. M., & Maier, S. F. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.042 · Cited by 17 · see citing works
Cao, M., Huang, X., Zou, J., Peng, Y., Wang, Y., Zheng, X., Tang, L., & Zhang, L. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.7.34 · Cited by 16 · see citing works
Lavagna, A., Auger, J.-P., Giradin, S. E., Gisch, N., Segura, M., & Gottschalk, M. G. (2020) · Pathogens · doi:10.3390/pathogens9020147 · Cited by 16 · see citing works
Piyasirananda, W., Beekman, A. M., Ganesan, A., Bidula, S. M., & Stokes, L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000129 · Cited by 16 · see citing works
GRK3 deficiency elicits brain immune activation and psychosis
Sellgren, C., Imbeault, S., Larsson, M., Oliveros, A., Nilsson, I. A. K., Codeluppi, S., Orhan, F., Bhat, M., Tufvesson-Alm, M., Gracias, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01106-0 · Cited by 14 · see citing works
Sharma, S., Dahiya, A., Kumar, S., Verma, Y. K., & Dutta, A. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100385 · Cited by 15 · see citing works
The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
Vultaggio-Poma, V., Sanz, J. M., Amico, A., Violi, A., Ghisellini, S., Pizzicotti, S., Passaro, A., Papi, A. A., Libanore, M., Virgilio, F. D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1182454 · Cited by 15 · see citing works
Self-citationCrucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis
Takeda, A., Yamada, H., Hasegawa, E., Arima, M., Notomi, S., Myojin, S., Yoshimura, T., Hisatomi, T., Enaida, H., Yanai, R., et al. (2018) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-018-0587-4 · Cited by 15 · see citing works
- Authors
- Giuliani, A. L., Sarti, A. C., Falzoni, S., & Di Virgilio, F.
- Affiliations
- University of Ferrara (IT)
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-16
- Volume
- 8
- Pages
- 123-123
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC5353276
- OpenAlex
- W2597076579
- Cited by
- 166
- References
- 126
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 12 · 2022: 17 · 2021: 23 · 2020: 28 · 2019: 20 · 2018: 29 · 2017: 8
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Ministero della Salute
- Università degli Studi di Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- P2X7 receptor, IL-1β, IL-1β maturation, NLRP3 inflammasome, caspase-1, ATP-gated ion channels, exocytosis, secretory lysosomes, microvesicles, exosomes, pyroptosis, innate immunity, inflammation, anti-inflammatory drug design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review